|
|
|
|
|
|
|
|
|
|
Experimental Information | |
Enzymatic Activity | |
Molecule Id | EGIN0005064 |
PMID | 23936329 |
Assay Used | Kinase assays |
Experimently Validated | Yes |
EGFR (IC50) | 160 ± 7 nM |
HER2 (IC50) | 840 ± 3 nM |
HER4 (IC50) | - |
Mutant L858R (IC50) | - |
Mutant T790M (IC50) | - |
Double Mutant (IC50) | - |
Average ERBB2 and ERBB1 (IC50) | - |
Inhibition EGFR (%) | - |
Inhibitory Concentration | - |
Inhibition HER2 (%) | - |
Inhibitory Concentration | - |
Ki (EGFR) | - |
Ki (HER2) | - |
Ki (HER4) | - |
Kd (EGFR) | - |
Kd (L858R) | - |
Kd (T790M) | - |
Kd (L858R/T790M) | - |
Kd (Other mutation) | - |
Note | - |
Extra | - |
Cellular Activity | ||||||||||||||
S.No. | Cell Line | Desp. | IC50 | IC80 | ED50 | GI50 | GI90 | EC50 | Kd | Inhibition (%) | Inhibitory Conc. | |||
1 | A549 | carcinomic human alveolar basal epithelial cell | 1390 ± 54nM | - | - | - | - | - | - | - | - | |||
2 | MCF-7 | breast cancer, with Her2/neu protein overexpression | 610 ± 5nM | - | - | - | - | - | - | - | - | |||
3 | A431 | overexpression of EGFR. | 740 ± 6nM | - | - | - | - | - | - | - | - | |||
Activity against Receptor | |
EGFR | Yes |
HER2 | Yes |
HER4 | - |
Wild type | Yes |
Mutant | - |
Inhibitor Binding | |
EGFR | - |
HER2 | - |
HER4 | - |